Gómez AVH

Language: Spanish
References: 15
Page: 102-104
PDF size: 109.55 Kb.

REFERENCES

1. Declemy A, Haddad R, Chesnel C, Charlanes A, Le Breton F, Sheikh Ismael S, et al. Prevalence of comorbidities in multiple sclerosis patients with neurogenic bladder. Prog Urol. 2021; 31 (12): 732-738.

2. Erden E, Ersoz M, Tiftik T, Erden E. The neurogenic bladder characteristics and treatment approaches in the patients with multiple sclerosis. Mult Scler Relat Disord. 2022; 58: 103439.

3. Benarroch EE. Neural control of the bladder: recent advances and neurologic implications. Neurology. 2010; 75 (20): 1839-1846.

4. Thomas S, Bradley J, Cole G, Girvan M, Metcalfe G, Naik P, et al. The neurogenic bladder: developing a consensus bladder and bowel management pathway for people with MS. Br J Nurs. 2022; 31 (21): 1088-1095.

5. Groen J, Pannek J, Castro Diaz D, Del Popolo G, Gross T, Hamid R, et al. Summary of European Association of Urology (EAU) Guidelines on Neuro-Urology. Eur Urol. 2016; 69 (2): 324-333.

6. Madhuvrata P, Singh M, Hasafa Z, Abdel-Fattah M. Anticholinergic drugs for adult neurogenic detrusor overactivity: a systematic review and meta-analysis. Eur Urol. 2012; 62 (5): 816-830.

7. Ginsberg D, Cruz F, Herschorn S, Gousse A, Keppenne V, Aliotta P, et al. OnabotulinumtoxinA is effective in patients with urinary incontinence due to neurogenic detrusor overactivity [corrected] regardless of concomitant anticholinergic use or neurologic etiology. Adv Ther. 2013; 30 (9): 819-833.

8. Wyndaele JJ, Kovindha A, Madersbacher H, Radziszewski P, Ruffion A, Schurch B, et al. Neurologic urinary incontinence. Neurourol Urodyn. 2010; 29 (1): 159-164.

9. Goetz LL, Cardenas DD, Kennelly M, Bonne Lee BS, Linsenmeyer T, Moser C, et al. International spinal cord injury urinary tract infection basic data set. Spinal Cord. 2013; 51 (9): 700-704.

10. Lombardi G, Nelli F, Celso M, Mencarini M, Del Popolo G. Treating erectile dysfunction and central neurological diseases with oral phosphodiesterase type 5 inhibitors. Review of the literature. J Sex Med. 2012; 9 (4): 970-985.

11. Forsythe E, Horsewell JE. Sexual rehabilitation of women with a spinal cord injury. Spinal Cord. 2006; 44 (4): 234-241.

12. Wyndaele JJ, Kovindha A, Igawa Y, Madersbacher H, Radziszewski P, Ruffion A, et al. Neurologic fecal incontinence. Neurourol Urodyn. 2010; 29 (1): 207-212.

13. Preziosi G, Gordon-Dixon A, Emmanuel A. Neurogenic bowel dysfunction in patients with multiple sclerosis: prevalence, impact, and management strategies. Degener Neurol Neuromuscul Dis. 2018; 8: 79-90.

14. Marrie RA, Reider N, Cohen J, Stuve O, Sorensen PS, Cutter G, et al. A systematic review of the incidence and prevalence of autoimmune disease in multiple sclerosis. Mult Scler. 2015; 21 (3): 282-293.

15. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord. 2010; 48 (10): 718-733.